Literature DB >> 24641420

Berberine hydrochloride impact on physiological processes and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells.

Cai-Hong Li1, Dong-Fang Wu, Hang Ding, Yang Zhao, Ke-Yuan Zhou, De-Feng Xu.   

Abstract

OBJECTIVE: The main purpose of this work was to investigate the effect of berberine hydrochloride (BH) on the proliferation, apoptosis, migration, and invasion of CNE-1 nasopharyngeal carcinoma cells. Our results shed light on the functional components of traditional Chinese herbs for potential use in modern medicine.
METHODS: The CNE-1 cell line was treated with different concentrations of BH and effects on cell viability and proliferation were evaluated using the Cell Counting Kit-8 (CCK-8) assay. Anti-migratory and anti-invasive actions of BH were investigated using wound healing assays and the Millicell Hanging cell culture insert system, respectively. Expression of the epithelial-mesenchymal transition (EMT)-related gene twist (Twist) was analyzed by real-time PCR and Western blotting. Apoptosis was estimated with an annexin-V fluorescein (FITC) apoptosis detection kit, as well as with reference to levels of activated caspase-3 of CNE-1 cells before and after treatment with BH utilizing fluorescence spectroscopy.
RESULTS: BH was capable of reducing proliferation and viability of CNE-1 cells in a dose- and time-dependent manner, also demonstrating anti-migratory and anti-invasive capacities which correlated with reduction in expression of Twist. Finally, BH was able to induce significant amounts of apoptosis in CNE-1 cells, as demonstrated by an increase in the activity of caspase-3 and in annexin-V staining following treatment.
CONCLUSION: BH extracted from rhizoma coptidis demonstrated an ability to block proliferation, induce apoptosis, and impair the migration and invasion of the CNE-1 cell line Considering these properties, our results suggest that BH could be an important compound for consideration in the treatment of nasopharyngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24641420     DOI: 10.7314/apjcp.2014.15.4.1851

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

Review 1.  Targeting Twist expression with small molecules.

Authors:  Haixiang Pei; Yunqi Li; Mingyao Liu; Yihua Chen
Journal:  Medchemcomm       Date:  2016-12-02       Impact factor: 3.597

Review 2.  From prejudice to evidence: the case of rhizoma coptidis in singapore.

Authors:  Chin Ee Ho; You Li Goh; Chang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-25       Impact factor: 2.629

Review 3.  Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review.

Authors:  Seyede Zohre Kamrani Rad; Maryam Rameshrad; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2017-05       Impact factor: 2.699

Review 4.  Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system.

Authors:  Kun Zou; Zhao Li; Yong Zhang; Hao-Yue Zhang; Bo Li; Wei-Liang Zhu; Ji-Ye Shi; Qi Jia; Yi-Ming Li
Journal:  Acta Pharmacol Sin       Date:  2016-12-05       Impact factor: 6.150

5.  Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.

Authors:  Lei Song; Yi Luo; Xinyue Wang; Mohammed M Almutairi; Huafeng Pan; Weirong Li; Yongqiang Liu; Qi Wang; Ming Hong
Journal:  Mol Med Rep       Date:  2019-09-23       Impact factor: 2.952

Review 6.  A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine.

Authors:  Da Liu; Xue Meng; Donglu Wu; Zhidong Qiu; Haoming Luo
Journal:  Front Pharmacol       Date:  2019-02-14       Impact factor: 5.810

7.  Berberine promotes XIAP-mediated cells apoptosis by upregulation of miR-24-3p in acute lymphoblastic leukemia.

Authors:  Jian Liu; Zhiwei Chen; Yunping Cui; Huixia Wei; Zhenjing Zhu; Fengxia Mao; Yingchao Wang; Yufeng Liu
Journal:  Aging (Albany NY)       Date:  2020-02-13       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.